Virginia bills · 2026 Regular Session
Virginia HB 1347
Psilocybin; Board of Pharmacy to reschedule upon federal scheduling changes.
- Introduced
- In committee
- Passed House
- Passed Senate
- To Governor
- Became law
Sponsors
- Laura Jane Cohen (Democratic)
Cosponsors (1)
- Garrett McGuire (Democratic)
Summary
Official abstract published by the Virginia legislature· SUMMARY AS PASSED
Board of Pharmacy; regulation of psilocybin. Directs the Board of Pharmacy to reschedule psilocybin consistent with federal scheduling upon approval by the U.S. Food and Drug Administration of a formulation of psilocybin designed to be administered by a health care professional in a health care setting. This bill is identical to SB 379.
Text versions
Roll-call votes
State vote data last updated Oct 15, 2026, 8:04 PM.
| Date | Vote | Result | Your legislators |
|---|---|---|---|
| Feb 25, 2026 House | H VOTE: | pass | Set your home in Virginia to see |
| Feb 23, 2026 Senate | Passage R | pass | Set your home in Virginia to see |
| Feb 20, 2026 Senate | Constitutional reading dispensed (on 2nd reading) | pass | Set your home in Virginia to see |
| Feb 19, 2026 Senate | Reported from Education and Health with substitute | pass | Set your home in Virginia to see |
| Feb 11, 2026 House | H VOTE: | pass | Set your home in Virginia to see |
| Feb 11, 2026 House | H VOTE: | pass | Set your home in Virginia to see |
| Feb 5, 2026 House | Reported from Health and Human Services | pass | Set your home in Virginia to see |
| Feb 3, 2026 House | Subcommittee recommends reporting | pass | Set your home in Virginia to see |
Actions
- Apr 6, 2026
Acts of Assembly Chapter text (CHAP0305) - Apr 6, 2026
Approved by Governor-Chapter 305 (effective 7/1/2026) - Mar 10, 2026
Governor's Action Deadline 11:59 p.m., April 13, 2026 - Mar 10, 2026 · House
Enrolled Bill communicated to Governor on March 10, 2026 - Mar 2, 2026 · Senate
Signed by President - Mar 2, 2026 · House
Signed by Speaker - Mar 2, 2026 · House
Fiscal Impact Statement from Department of Planning and Budget (HB1347) - Mar 2, 2026 · House
Bill text as passed House and Senate (HB1347ER) - Mar 2, 2026 · House
Enrolled - Feb 25, 2026 · House
Senate substitute agreed to by House (96-Y 0-N 0-A) - Feb 23, 2026 · Senate
Passed Senate with substitute Block Vote (38-Y 0-N 0-A) - Feb 23, 2026 · Senate
Engrossed by Senate - committee substitute - Feb 23, 2026 · Senate
Education and Health Substitute agreed to - Feb 23, 2026 · Senate
Read third time - Feb 20, 2026 · House
Fiscal Impact Statement from Department of Planning and Budget (HB1347) - Feb 20, 2026 · Senate
Committee substitute printed 26108278D-S1 - Feb 20, 2026 · Senate
Passed by for the day (Voice Vote) - Feb 20, 2026 · Senate
Constitutional reading dispensed (on 2nd reading) (40-Y 0-N 0-A) - Feb 20, 2026 · Senate
Rules suspended - Feb 19, 2026 · Senate
Senate committee offered - Feb 19, 2026 · Senate
Reported from Education and Health with substitute (15-Y 0-N) - Feb 12, 2026 · Senate
Referred to Committee on Education and Health - Feb 12, 2026 · Senate
Constitutional reading dispensed (on 1st reading) - Feb 11, 2026 · House
Passed House (98-Y 0-N 0-A) - Feb 11, 2026 · House
Reconsideration of passage agreed to by House - Feb 11, 2026 · House
Read third time and passed House (96-Y 0-N 0-A) - Feb 10, 2026 · House
Read second time and engrossed - Feb 9, 2026 · House
Fiscal Impact Statement from Department of Planning and Budget (HB1347) - Feb 9, 2026 · House
Read first time - Feb 5, 2026 · House
Reported from Health and Human Services (22-Y 0-N) - Feb 3, 2026 · House
Subcommittee recommends reporting (9-Y 1-N) - Jan 23, 2026 · House
Assigned sub: Health - Jan 19, 2026 · House
Referred to Committee on Health and Human Services - Jan 19, 2026 · House
Presented and ordered printed 26105580D